ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 121 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $93,000 | -66.3% | 17,561 | -69.5% | 0.00% | -100.0% |
| Q1 2021 | $276,000 | +60.5% | 57,484 | +44.4% | 0.00% | +100.0% |
| Q4 2020 | $172,000 | -49.3% | 39,822 | -51.7% | 0.00% | -80.0% |
| Q3 2020 | $339,000 | +1203.8% | 82,363 | +721.4% | 0.01% | – |
| Q2 2020 | $26,000 | -77.2% | 10,027 | -66.8% | 0.00% | -100.0% |
| Q4 2019 | $114,000 | -7.3% | 30,177 | +52.4% | 0.00% | 0.0% |
| Q2 2019 | $123,000 | -41.7% | 19,803 | -19.9% | 0.00% | -50.0% |
| Q4 2018 | $211,000 | -79.9% | 24,720 | -52.8% | 0.00% | -84.6% |
| Q3 2018 | $1,049,000 | -68.7% | 52,400 | -59.7% | 0.01% | -70.5% |
| Q2 2018 | $3,355,000 | +301.3% | 129,874 | +271.2% | 0.04% | +238.5% |
| Q1 2018 | $836,000 | +8.0% | 34,992 | +53.3% | 0.01% | 0.0% |
| Q4 2017 | $774,000 | +223.8% | 22,828 | +102.1% | 0.01% | +160.0% |
| Q3 2017 | $239,000 | – | 11,296 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 984,329 | $6,999,000 | 4.03% |
| Broadfin Capital, LLC | 2,469,894 | $17,561,000 | 3.63% |
| Healthcare Value Capital, LLC | 100,000 | $711,000 | 2.74% |
| ARMISTICE CAPITAL, LLC | 2,744,000 | $19,510,000 | 1.07% |
| DELTEC ASSET MANAGEMENT LLC | 536,836 | $3,817,000 | 0.84% |
| SECTORAL ASSET MANAGEMENT INC | 808,924 | $5,751,000 | 0.69% |
| Mosaic Family Wealth, LLC | 91,314 | $649,000 | 0.26% |
| Worth Venture Partners, LLC | 59,740 | $425,000 | 0.24% |
| EMERALD ADVISERS, LLC | 626,247 | $4,453,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 565,319 | $4,019,000 | 0.16% |